Company Intelligence Profile
Claritrics India Private Limited
Claritrics India Private Limited is the Chennai-based Indian delivery/operations subsidiary of Claritrics Inc.
Last updated 4 August 2026
Claritrics India Private Limited, based in Chennai, operates as the Indian delivery and operations subsidiary of Claritrics Inc., focusing on automating healthcare revenue-cycle management. In FY2023, the company experienced a revenue growth of 12.35% within the Rs 25, 50 crore range, improved EBITDA by 43.76%, but faced a net profit margin decline of 2.01%, resulting in a net loss.
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
See what AICA knows about Claritrics India
Deeper analysis, financial signals and peer comparisons.
Company Identity
| Registered name | Claritrics India Private Limited |
|---|---|
| CIN | U72200TN2018PTC123179 |
| PAN | AAHCC6213H |
| Status | Active |
| Listing | Unlisted (private limited company; not listed on any stock exchange) |
| Incorporated | 12 June 2018 |
| ROC | RoC Chennai / Tamil Nadu |
| Sector (NIC) |
|
| Registered address | 46/50, Indira Nagar Main Road, Opposite Ann Hospital, Valasaravakkam, Chennai, Tamil Nadu 600087 |
| Authorized capital | Rs 45.00 lakh |
| Paid-up capital | Rs 44.03 lakh |
Business Overview
- Claritrics India Private Limited is the Chennai-based Indian delivery/operations subsidiary of Claritrics Inc. (New York, USA), which trades under the consumer brand "BUDDI.AI." The group builds a deep-learning/AI platform automating healthcare revenue-cycle management — autonomous medical coding, claim-denial prevention, clinical documentation improvement, patient registration, billing automation and prior-authorization processing — serving US healthcare providers, payers and health information exchanges
- Founded in 2013 by Ram (Ramachandran) Swaminathan, Sudarsun Santhiappan and Venkatesh Prabhu (Gopalan); platform is described as HIPAA/SOC 2 compliant, deployed on Microsoft Azure, with an IIT-Madras research partnership
- Confirmed: the corporate website claritrics.com 301-redirects to buddi.ai — same operating entity, brand renamed to BUDDI.AI
Directors
Current (per TheCompanyCheck, appointment dates shown; DINs per Tofler):
| Name | DIN | Role | Appointed |
|---|---|---|---|
| Ramachandran Swaminathan | 06817363 | Director | 29 Mar 2019 |
| Malathi Swaminathan | 08246975 | Director | 02 Sep 2024 |
GST Registrations
| GSTIN | State | PAN | Status |
|---|---|---|---|
| 33AAHCC6213H1ZZ | Tamil Nadu | AAHCC6213H (Tofler) | Active |
| 07AAHCC6213H1ZU | Delhi | AAHCC6213H (Tofler) | Cancelled |
Primary GSTIN: 33AAHCC6213H1ZZ (Tamil Nadu, state code 33) — registered 09 Feb 2019, Regular taxpayer, Active. PAN AAHCC6213H matches company PAN (Tofler) — no entity-confusion risk. One additional GSTIN found: 07AAHCC6213H1ZU (Delhi, state code 07) — status Cancelled. Total registrations found: 2 (1 active, 1 cancelled). Home state: Tamil Nadu.
Financials
Latest audited FY referenced: FY2023 (year ended March 2023), standalone basis.
| Revenue | Rs 25–50 crore band, +12.35% YoY — exact figure paywalled |
|---|---|
| EBITDA | exact figure paywalled; +43.76% YoY |
| PAT | declined -25.78% YoY; net profit margin -2.01% (loss-making on this metric) |
| Net worth | +48.33% YoY |
| Total borrowings | +1024.91% YoY; debt-to-equity 2.29; ROE -32.54% |
| AGM | 21 Dec 2024; balance sheet filed as of 31 Mar 2024 (InstaFinancials) |
Overall picture: growing revenue, improving EBITDA, but a net loss and sharply higher leverage in FY23 — precise Rs-crore figures not obtained; no Screener/Moneycontrol data available since the company is private/unlisted.
Funding
- No India-entity-specific funding round found (this is an operating subsidiary, not typically a separate fundraising vehicle)
- At the parent (Claritrics Inc./BUDDI.AI, US) level: Tracxn/Crunchbase/Dealroom show one recorded early round — ~$201,000, Venture (series unknown), dated 15 Sep 2013, investors including Bluehill VC and Keiretsu Forum (4 investors total, 2 unnamed)
- Separately, "ASA Capital acquired BUDDI AI (Claritrics Inc.)" in 2020 per a Dealroom-indexed listing (dealert.ai) — deal size not disclosed in any source checked
- Round names only, per Tracxn-sourcing rule; treat as parent-company/indicative, not confirmed India-entity funding
Charges & Loans
- One open charge found: HDFC Bank Limited — Rs 2.0 crore — charge created 19 Jan 2023
- No other charges located
Legal / Litigation
Indian Kanoon — two matters found naming the company as party: 1. Claritrics India Private Limited vs The Assistant Commissioner (ST), Madras High Court, order dated 04 Sep 2024 (Justice Krishnan Ramasamy) — a GST/sales-tax dispute; company represented by Director Ramachandran Swaminathan. 2. Claritrics India Private Limited vs DCIT, Corporate Circle 1(1), Chennai — Income Tax Appellate Tribunal, Chennai, dated 04 Aug 2025, Assessment Year 2021-22 — company as appellant. No other litigation found.
Competitors
AI-driven medical coding / healthcare RCM automation peers (buddi.ai's actual competitive set):
- Fathom Health (US) — autonomous medical coding, claims millions of charts/day processed — similar/larger scale
- Nym Health (US/Israel) — autonomous AI medical coding engine — similar scale
- CodaMetrix (US) — AI autonomous coding platform backed by major US health systems — larger scale
- 3M Health Information Systems (US) — legacy/incumbent computer-assisted coding vendor — much larger, established incumbent
- R1 RCM / Optum360 (US) — large-scale healthcare revenue-cycle BPO/tech providers — much larger scale
- Indian RCM/medical-coding BPO peers for context: Omega Healthcare, AGS Health (both Indian-origin healthcare RCM/BPO firms) — comparable or larger scale in the India-delivery RCM space
Frequently Asked Questions
What does Claritrics India Private Limited do?
What is the CIN of Claritrics India Private Limited?
Where is Claritrics India Private Limited registered?
When was Claritrics India Private Limited incorporated?
Recur Market
Which lenders fit a company like Claritrics India Private Limited?
Answer a few questions about your business and see which banks and NBFCs match, with indicative rates.
More on Recur Club
Recently added companies
Explore on Recur Club
More from Recur Club
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.